In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity
Gabriel E. Molina, Ben Schwartz, Sandy Srinivas, Sumit Shah, Lisa C. Zaba
Topics & Concepts
MedicineToxicityUrothelial carcinomaOncologyInternal medicineMerkel cell carcinomaCarcinomaBladder cancerCancerBladder and Urothelial Cancer TreatmentsGenital Health and DiseaseProstate Cancer Diagnosis and Treatment